Todd Hayashida Driver, MD
Ophthalmology · Irvine
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Daniel C. Kline, M.D., Inc. · 6 clinicians in this group
Looking this up.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Driver’s office at (949) 653-9500 to ask if they take your plan before you enroll.
California Medical Board record
Licence A140821 · Current
Licensed to practise in California · since 2016 · expires 2027-04-30 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Newport Bay Sugery Center, LLC dba Newport Bay Surgery CenterAmbulatory Surgery Center · Newport Beach, CA1.49% owner since 2023 · accredited by AAAHCAccreditation Renewed2 inspections · last 2025-07-28
Original Medicare doctor bills
$166,795
Medicare paid this office $166,795 for 556 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Established patient complete exam of visual system | 445 | $57,281 | $94 |
| Removal of cataract with insertion of prosthetic lens | 40 | $31,352 | $461 |
| Closure of tear duct opening using plug | 59 | $15,203 | $169 |
| Removal of recurring cataract in lens capsule using a laser | 41 | $14,864 | $297 |
| Established patient problem focused exam of visual system | 82 | $9,789 | $75 |
See all 11 services
| Established patient complete exam of visual system | 445 | $57,281 | $94 |
| Removal of cataract with insertion of prosthetic lens | 40 | $31,352 | $461 |
| Closure of tear duct opening using plug | 59 | $15,203 | $169 |
| Removal of recurring cataract in lens capsule using a laser | 41 | $14,864 | $297 |
| Established patient problem focused exam of visual system | 82 | $9,789 | $75 |
| Imaging of retina | 263 | $8,579 | $32 |
| New patient complete exam of visual system | 77 | $8,427 | $109 |
| Exam of visual field with extended testing | 151 | $8,057 | $52 |
| Imaging of optic nerve | 135 | $3,594 | $26 |
| Measurement of corneal curvature and depth of eye | 59 | $2,659 | $32 |
| Ultrasound scan of cornea to determine thickness | 16 | $120 | $8 |
Procedures Medicare counted
| Cataract surgery | 150 | More than 80% of doctors who do this |
Who their Medicare patients are
556 Original Medicare patients in 2024. Average age 75 · Women 59% · Health risk score 0.98. At or below the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 67% · Diabetes 22% · Cancer 21% · Coronary heart disease 20% · Chronic kidney disease 19% · Depression 15% · Atrial fibrillation 14% · COPD 9% · Heart failure 6% · Stroke 6% · Dementia 4%.
The office billed $556,490, Medicare allowed $230,611 and paid $166,795; for 1,736 services of 27 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 556 | 1,736 | 75 | 0.98 | $556,490 | $166,795 |
| 2023 | 653 | 1,965 | 76 | 0.93 | $570,330 | $174,141 |
| 2022 | 574 | 1,732 | 75 | 0.95 | $471,485 | $147,630 |
| 2021 | 527 | 1,470 | 75 | 0.91 | $379,135 | $124,431 |
| 2020 | 362 | 940 | 74 | 0.85 | $221,730 | $76,794 |
| 2019 | 214 | 402 | 74 | 1.01 | $157,972 | $36,882 |
| 2018 | 42 | 70 | 73 | 1.66 | $80,254 | $6,723 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Established patient complete exam of visual system | 514 | $65,279 | $93 |
| Removal of cataract with insertion of prosthetic lens | 33 | $25,636 | $466 |
| Closure of tear duct opening using plug | 48 | $11,799 | $176 |
| New patient complete exam of visual system | 99 | $11,112 | $112 |
| Exam of visual field with extended testing | 181 | $9,871 | $52 |
| Imaging of retina | 298 | $9,792 | $32 |
| Established patient problem focused exam of visual system | 84 | $9,617 | $69 |
| Removal of recurring cataract in lens capsule using a laser | 27 | $9,339 | $292 |
| Imaging of optic nerve | 161 | $4,350 | $26 |
| Measurement of corneal curvature and depth of eye | 54 | $2,734 | $35 |
| Exam of the internal drainage system of eye | 26 | $486 | $18 |
| Extended exam of the back part of the eye with retinal drawing | 12 | $191 | $15 |
| Ultrasound scan of cornea to determine thickness | 28 | $177 | $6 |
2022: 13 services
| Established patient complete exam of visual system | 469 | $60,809 | $95 |
| Removal of cataract with insertion of prosthetic lens | 26 | $18,468 | $474 |
| Closure of tear duct opening using plug | 32 | $9,241 | $168 |
| New patient complete exam of visual system | 89 | $9,032 | $101 |
| Exam of visual field with extended testing | 162 | $8,956 | $54 |
| Imaging of retina | 262 | $8,760 | $32 |
| Removal of recurring cataract in lens capsule using a laser | 20 | $7,624 | $282 |
| Established patient problem focused exam of visual system | 62 | $6,370 | $70 |
| Imaging of optic nerve | 159 | $4,510 | $28 |
| Measurement of corneal curvature and depth of eye | 36 | $1,787 | $34 |
| Exam of the internal drainage system of eye | 27 | $623 | $23 |
| Ultrasound scan of cornea to determine thickness | 32 | $337 | $10 |
| Extended exam of the back part of the eye with retinal drawing | 16 | $332 | $17 |
2021: 13 services
| Established patient complete exam of visual system | 360 | $47,555 | $99 |
| Removal of cataract with insertion of prosthetic lens | 21 | $15,571 | $472 |
| New patient complete exam of visual system | 137 | $15,379 | $112 |
| Established patient problem focused exam of visual system | 80 | $8,567 | $74 |
| Imaging of retina | 210 | $7,211 | $33 |
| Exam of visual field with extended testing | 125 | $7,140 | $56 |
| Closure of tear duct opening using plug | 23 | $6,803 | $139 |
| Removal of recurring cataract in lens capsule using a laser | 12 | $4,330 | $289 |
| Imaging of optic nerve | 120 | $3,654 | $30 |
| Measurement of corneal curvature and depth of eye | 32 | $1,792 | $44 |
| Extended exam of the back part of the eye with retinal drawing | 29 | $759 | $21 |
| Exam of the internal drainage system of eye | 17 | $407 | $24 |
| Ultrasound scan of cornea to determine thickness | 24 | $219 | $9 |
2020: 10 services
| Established patient complete exam of visual system | 259 | $33,045 | $97 |
| New patient complete exam of visual system | 90 | $9,239 | $103 |
| Closure of tear duct opening using plug | 19 | $5,125 | $190 |
| Exam of visual field with extended testing | 86 | $5,053 | $55 |
| Imaging of retina | 111 | $3,808 | $33 |
| Established patient problem focused exam of visual system | 34 | $3,387 | $75 |
| Imaging of optic nerve | 74 | $2,112 | $28 |
| Extended exam of the back part of the eye with retinal drawing | 35 | $844 | $21 |
| Photography of the retina | 12 | $413 | $34 |
| Ultrasound scan of cornea to determine thickness | 18 | $184 | $10 |
2019: 7 services
| Established patient complete exam of visual system | 112 | $13,366 | $108 |
| New patient complete exam of visual system | 37 | $4,555 | $123 |
| Established patient problem focused exam of visual system | 50 | $4,266 | $70 |
| Exam of visual field with extended testing | 23 | $1,336 | $58 |
| Imaging of retina | 33 | $1,245 | $35 |
| Imaging of optic nerve | 24 | $727 | $30 |
| Photography of content of eyes | 14 | $300 | $21 |
2018: 1 service
| Established patient problem focused exam of visual system | 11 | $1,023 | $85 |
Drugs they prescribed that Part D paid
$214,186
Pharmacies billed $214,186 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,607) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
807 generic and 800 brand-name prescriptions · $214,186 in drug cost · 22 antibiotic prescriptions to 17 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Restasis | 55 | $41,742 | $759 |
| Xiidra | 18 | $28,594 | $1,589 |
| Lumigan | 42 | $23,499 | $560 |
| Cyclosporine | 35 | $20,562 | $587 |
| Vyzulta | 22 | $11,266 | $512 |
See all 22 drugs
| Restasis | 55 | $41,742 | $759 |
| Xiidra | 18 | $28,594 | $1,589 |
| Lumigan | 42 | $23,499 | $560 |
| Cyclosporine | 35 | $20,562 | $587 |
| Vyzulta | 22 | $11,266 | $512 |
| Miebo | 14 | $10,128 | $723 |
| Latanoprost | 566 | $9,100 | $16 |
| Brimonidine | 122 | $6,681 | $55 |
| Zirgan | 13 | $5,939 | $457 |
| Prednisolone Acetate | 154 | $4,687 | $30 |
| Dorzolamide-Timolol | 25 | $3,862 | $154 |
| Travoprost | 27 | $2,913 | $108 |
| Simbrinza | 15 | $2,895 | $193 |
| Tobramycin-Dexamethasone | 72 | $2,835 | $39 |
| Dorzolamide-Timolol | 89 | $2,433 | $27 |
| Brimonidine Tartrate-Timolol | 13 | $2,062 | $159 |
| Valacyclovir | 22 | $1,495 | $68 |
| Timolol Maleate | 130 | $1,402 | $11 |
| Brinzolamide | 13 | $1,175 | $90 |
| Dorzolamide | 31 | $1,152 | $37 |
| Moxifloxacin | 18 | $897 | $50 |
| Doxycycline Hyclate | 26 | $580 | $22 |
Year by year
| 2024 | 1,607 | 485 | 0% (0) | 50% | $214,186 |
| 2023 | 1,689 | 527 | 0% (0) | 53% | $280,100 |
| 2022 | 1,438 | 449 | 0% (0) | 55% | $214,415 |
| 2021 | 1,221 | 436 | 0% (0) | 56% | $196,313 |
| 2020 | 786 | 308 | 0% (0) | 56% | $114,737 |
| 2019 | 309 | 146 | 0% (0) | 51% | $39,220 |
| 2018 | 213 | 89 | 0% (0) | 47% | $17,809 |
| 2017 | 214 | 65 | 0% (0) | 42% | $19,161 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 21 drugs
| Restasis | 77 | $68,622 | $891 |
| Xiidra | 38 | $54,030 | $1,422 |
| Lumigan | 41 | $22,493 | $549 |
| Cyclosporine | 38 | $18,910 | $498 |
| Alphagan P | 36 | $15,730 | $437 |
| Latanoprost | 582 | $15,502 | $27 |
| Vyzulta | 22 | $13,101 | $595 |
| Tobramycin-Dexamethasone | 95 | $5,718 | $60 |
| Prednisolone Acetate | 153 | $5,344 | $35 |
| Dorzolamide-Timolol | 111 | $5,064 | $46 |
| Combigan | 17 | $4,726 | $278 |
| Simbrinza | 18 | $4,577 | $254 |
| Dorzolamide-Timolol | 28 | $3,840 | $137 |
| Brimonidine Tartrate-Timolol | 11 | $3,421 | $311 |
| Travoprost | 15 | $3,199 | $213 |
| Brimonidine | 81 | $3,000 | $37 |
| Timolol Maleate | 135 | $2,262 | $17 |
| Dorzolamide | 46 | $1,793 | $39 |
| Valacyclovir | 28 | $1,695 | $61 |
| Moxifloxacin | 20 | $690 | $35 |
| Doxycycline Hyclate | 17 | $520 | $31 |
2022: 18 drugs
| Restasis | 36 | $38,928 | $1,081 |
| Alphagan P | 81 | $28,805 | $356 |
| Xiidra | 20 | $27,095 | $1,355 |
| Lumigan | 40 | $18,680 | $467 |
| Latanoprost | 452 | $15,988 | $35 |
| Combigan | 26 | $10,165 | $391 |
| Vyzulta | 22 | $6,835 | $311 |
| Prednisolone Acetate | 150 | $6,085 | $41 |
| Tobramycin-Dexamethasone | 77 | $5,900 | $77 |
| Simbrinza | 18 | $5,136 | $285 |
| Dorzolamide-Timolol | 87 | $3,468 | $40 |
| Valacyclovir | 23 | $2,791 | $121 |
| Timolol Maleate | 141 | $2,527 | $18 |
| Dorzolamide | 48 | $1,878 | $39 |
| Moxifloxacin | 38 | $1,803 | $47 |
| Brimonidine | 34 | $1,742 | $51 |
| Neomycin-Polymyxin-Dexameth | 19 | $269 | $14 |
| Erythromycin | 12 | $122 | $10 |
2021: 22 drugs
| Restasis | 32 | $39,733 | $1,242 |
| Alphagan P | 68 | $20,561 | $302 |
| Xiidra | 17 | $18,555 | $1,091 |
| Lumigan | 26 | $11,878 | $457 |
| Latanoprost | 294 | $11,292 | $38 |
| Tobramycin-Dexamethasone | 114 | $9,398 | $82 |
| Combigan | 13 | $8,069 | $621 |
| Durezol | 39 | $7,971 | $204 |
| Prolensa | 26 | $7,922 | $305 |
| Simbrinza | 19 | $6,266 | $330 |
| Vyzulta | 21 | $5,569 | $265 |
| Prednisolone Acetate | 128 | $5,162 | $40 |
| Ilevro | 14 | $4,406 | $315 |
| Moxifloxacin | 108 | $4,141 | $38 |
| Dorzolamide-Timolol | 14 | $3,297 | $235 |
| Dorzolamide-Timolol | 45 | $2,221 | $49 |
| Valacyclovir | 14 | $1,783 | $127 |
| Timolol Maleate | 89 | $1,573 | $18 |
| Doxycycline Hyclate | 16 | $409 | $26 |
| Dorzolamide | 14 | $408 | $29 |
| Erythromycin | 16 | $217 | $14 |
| Neomycin-Polymyxin-Dexameth | 11 | $149 | $14 |
2020: 18 drugs
| Pazeo | 28 | $12,392 | $443 |
| Lumigan | 16 | $10,134 | $633 |
| Alphagan P | 31 | $8,804 | $284 |
| Durezol | 39 | $7,908 | $203 |
| Tobramycin-Dexamethasone | 84 | $7,713 | $92 |
| Ilevro | 22 | $6,674 | $303 |
| Combigan | 17 | $5,356 | $315 |
| Simbrinza | 22 | $4,946 | $225 |
| Latanoprost | 146 | $4,793 | $33 |
| Prednisolone Acetate | 75 | $3,092 | $41 |
| Travoprost | 11 | $2,662 | $242 |
| Valacyclovir | 11 | $1,978 | $180 |
| Olopatadine | 22 | $1,740 | $79 |
| Moxifloxacin | 36 | $1,577 | $44 |
| Dorzolamide-Timolol | 22 | $1,259 | $57 |
| Timolol Maleate | 49 | $806 | $16 |
| Doxycycline Hyclate | 20 | $696 | $35 |
| Neomycin-Polymyxin-Dexameth | 12 | $214 | $18 |
2019: 9 drugs
| Lotemax | 20 | $9,307 | $465 |
| Alrex | 11 | $3,761 | $342 |
| Pazeo | 11 | $3,316 | $301 |
| Valacyclovir | 16 | $2,837 | $177 |
| Fluorometholone | 28 | $2,529 | $90 |
| Prednisolone Acetate | 33 | $1,764 | $53 |
| Moxifloxacin | 25 | $1,494 | $60 |
| Latanoprost | 25 | $479 | $19 |
| Polymyxin B Sul-Trimethoprim | 12 | $89 | $7 |
2018: 5 drugs
| Prednisolone Acetate | 26 | $1,781 | $68 |
| Dorzolamide-Timolol | 24 | $368 | $15 |
| Latanoprost | 30 | $357 | $12 |
| Ketorolac Tromethamine | 12 | $335 | $28 |
| Ciprofloxacin | 26 | $276 | $11 |
2017: 6 drugs
| Alphagan P | 17 | $5,379 | $316 |
| Brimonidine | 25 | $4,666 | $187 |
| Prednisolone Acetate | 24 | $1,637 | $68 |
| Dorzolamide-Timolol | 37 | $710 | $19 |
| Latanoprost | 56 | $685 | $12 |
| Ciprofloxacin | 23 | $251 | $11 |
Money from drug and device companies
$533 in 2025
| 2025 | 9 | 19 | None | $533 |
| 2024 | 10 | 11 | None | $651 |
| 2023 | 10 | 20 | None | $817 |
| 2022 | 9 | 15 | None | $585 |
| 2021 | 8 | 12 | None | $672 |
| 2020 | 4 | 5 | None | $92 |
| 2019 | 1 | 1 | None | $25 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Johnson & Johnson Surgical Vision | Tecnis Iol | $126 | 2 payments
|
| Harrow Eye | Vevye | $91 | 3 payments
|
| Alcon Vision | Clareon | $89 | 4 payments
|
| Rayner Intraocular Lenses | Omidria | $48 | 2 payments
|
| Bausch & Lomb Americas | Miebo | $44 | 2 payments
|
| Sun Pharmaceutical Industries | Cequa | $43 | 2 payments
|
See all 19 published payments
| Rayner Intraocular Lenses | Meals · 2025-12-19 | Omidria | $29 |
| Glaukos | Meals · 2025-12-19 | Istent Infinite | $39 |
| Alcon Vision | Meals · 2025-12-01 | Clareon Panoptix Pro | $17 |
| Rayner Intraocular Lenses | Meals · 2025-11-21 | Omidria | $20 |
| Johnson & Johnson Surgical Vision | Meals · 2025-11-13 | Catalys System | $21 |
| Thea Pharma | Meals · 2025-11-03 | Iyuzeh | $22 |
| Alcon Vision | Meals · 2025-10-06 | Rocklatan | $26 |
| Harrow Eye | Meals · 2025-09-19 | Vevye | $32 |
| Amgen | Meals · 2025-09-08 | Tepezza | $15 |
| Bausch & Lomb Americas | Meals · 2025-08-06 | Miebo | $21 |
| Sun Pharmaceutical Industries | Meals · 2025-06-16 | Cequa | $23 |
| Alcon Vision | Meals · 2025-06-11 | Dailies Total1 | $19 |
| Harrow Eye | Meals · 2025-06-02 | Vevye | $37 |
| Amgen | Meals · 2025-05-16 | Tepezza | $16 |
| Harrow Eye | Meals · 2025-05-14 | Iheezo | $22 |
| Sun Pharmaceutical Industries | Meals · 2025-04-29 | Cequa | $20 |
| Alcon Vision | Meals · 2025-04-07 | Clareon | $27 |
| Bausch & Lomb Americas | Meals · 2025-02-19 | Miebo | $23 |
| Johnson & Johnson Surgical Vision | Meals · 2025-02-06 | Tecnis Iol | $104 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $651
| Alcon Vision | Argos | $165 | 2 payments
|
| Sight Sciences | Omni Surgical System | $156 | 1 payment
|
| Glaukos | Idose | $112 | 1 payment
|
| Lensar | Lensar Laser System | $76 | 1 payment
|
| Sun Pharmaceutical Industries | Cequa | $34 | 1 payment
|
| Amgen | Tepezza | $26 | 1 payment
|
| Thea Pharma | Iyuzeh | $24 | 1 payment
|
| Abbvie | Lumigan | $23 | 1 payment
|
| Bausch & Lomb Americas | Miebo | $20 | 1 payment
|
| RxSight | Rxsight Contact Lens | $14 | 1 payment
|
2023: $817
| Alcon Vision | Argos | $284 | 3 payments
|
| RxSight | Rxsight Contact Lens | $181 | 6 payments
|
| Johnson & Johnson Surgical Vision | Tecnis Iol | $174 | 3 payments
|
| Novartis Pharmaceuticals | Xiidra | $44 | 2 payments
|
| Optos | Nfc-700 | $31 | 1 payment
|
| AbbVie | Lumigan | $27 | 1 payment
|
| Oyster Point Pharma | Tyrvaya | $23 | 1 payment
|
| Bausch & Lomb Americas | Vyzulta | $20 | 1 payment
|
| Thea Pharma | None | $18 | 1 payment
|
| Glaukos | None | $16 | 1 payment
|
2022: $585
| Johnson & Johnson Surgical Vision | Tecnis Iol | $270 | 5 payments
|
| Alcon Vision | Argos | $151 | 2 payments
|
| Oyster Point Pharma | Tyrvaya | $36 | 2 payments
|
| Glaukos | Iaccess | $25 | 1 payment
|
| Abbvie | Vuity | $24 | 1 payment
|
| Eyevance Pharmaceuticals | Tobradex St | $21 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $19 | 1 payment
|
| Bausch & Lomb Americas | Vyzulta | $19 | 1 payment
|
| Thea Pharma | None | $19 | 1 payment
|
2021: $672
| Alcon Vision | Acrysof Iq Panoptix | $161 | 1 payment
|
| Spark Therapeutics | None | $125 | 1 payment
|
| Horizon Therapeutics plc | Tepezza | $123 | 1 payment
|
| Genentech USA | None | $106 | 1 payment
|
| Allergan | Restasis Multidose | $59 | 3 payments
|
| Glaukos | Istent Inject W | $42 | 2 payments
|
| RxSight | Light Adjustable Lens (Lal) and Light Delivery Device (Ldd) | $33 | 2 payments
|
| Aerie Pharmaceuticals | Rhopressa | $23 | 1 payment
|
2020: $92
| Aerie Pharmaceuticals | Rocklatan | $30 | 2 payments
|
| Novartis Pharmaceuticals | Xiidra | $23 | 1 payment
|
| RxSight | Light Adjustable Lens (Lal) and Light Delivery Device (Ldd) | $20 | 1 payment
|
| Carl Zeiss Meditec AG | None Specified | $19 | 1 payment
|
2019: $25
| Bausch & Lomb a division of Bausch Health US | Vyzulta | $25 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 26.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1245650985
- Licence
- CA A140821California A140821: Current · expires 2027-04-30
- Trained
- University of California, San Francisco School of Medicine, 2014
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 9 Corporate Park Ste 150, Irvine, CA, 92606
- NPI first listed
- 2014-04-21
- NPI last updated
- 2023-06-14
- NPI record certified
- 2023-06-14
This is when the NPI record was last certified, not a medical board exam.